Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Aberrant expression of microRNA in polycythemia vera

H Bruchova, M Merkerova, JT Prchal

. 2008 ; 93 (7) : 1009-1016.

Jazyk angličtina Země Itálie

Typ dokumentu Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14065282

Grantová podpora
NR9236 MZ0 CEP - Centrální evidence projektů

BACKGROUND: Polycythemia vera is a clonal hematopoietic stem cell disorder in which the JAK2 V617F mutation is observed in >95% of patients, but an as yet unidentified process appears to initiate the clonal expansion of hematopoiesis. Because microRNA regulate hematopoietic differentiation, we hypothesized that dysregulated expression of microRNA may contribute to the pathophysiology of polycythemia vera. DESIGN AND METHODS: We performed gene expression profiling in five patients with polycythemia vera and in five controls using CombiMatrix MicroRNA CustomArray. ANOVA identified deregulated microRNA in polycythemia vera, and their expression was studied in a larger set of samples by quantitative reverse transcriptase polymerase chain reaction. The expression of these microRNA was also analyzed in other myeloproliferative disorders. RESULTS: We observed down-regulation of let-7a and up-regulation of miR-182 in polycythemia vera granulocytes, up-regulation of miR-143, miR-145 and miR-223 in polycythemia vera mononuclear cells, up-regulation of miR-26b in polycythemia vera platelets, and down-regulation of miR-30b, miR-30c and miR-150 in polycythemia vera reticulocytes. JAK2 V617F frequency was positively correlated with miR-143 expression and inversely correlated with let-7a, miR-30c, miR-342 and miR-150. Transcript level of predicted target genes was determined, and overexpression of IRAK2 was detected in all granulocytes from patients with myeloproliferative disorders and in polycythemia vera reticulocytes. Abnormally high HMGA2 microRNA was found in myelofibrosis granulocytes. CONCLUSIONS: Our study demonstrates that peripheral blood cells from patients with polycythemia vera have microRNA signatures distinct from those of controls. Our findings of aberrant microRNA expression underline the complexity of the molecular basis of polycythemia vera.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14065282
003      
CZ-PrNML
005      
20190104130000.0
007      
ta
008      
140714s2008 it ad f 000 0|eng||
009      
AR
024    7_
$a 10.3324/haematol.12706 $2 doi
035    __
$a (PubMed)18508790
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a it
100    1_
$a Votavová, Hana $7 xx0081900 $u University of Utah, School of Medicine, Hematology Division, Salt Lake City, Utah 84132, USA; Institute of Hematology and Blood Transfusion, Prague, Czech Republic
245    10
$a Aberrant expression of microRNA in polycythemia vera / $c H Bruchova, M Merkerova, JT Prchal
504    __
$a Literatura
520    9_
$a BACKGROUND: Polycythemia vera is a clonal hematopoietic stem cell disorder in which the JAK2 V617F mutation is observed in >95% of patients, but an as yet unidentified process appears to initiate the clonal expansion of hematopoiesis. Because microRNA regulate hematopoietic differentiation, we hypothesized that dysregulated expression of microRNA may contribute to the pathophysiology of polycythemia vera. DESIGN AND METHODS: We performed gene expression profiling in five patients with polycythemia vera and in five controls using CombiMatrix MicroRNA CustomArray. ANOVA identified deregulated microRNA in polycythemia vera, and their expression was studied in a larger set of samples by quantitative reverse transcriptase polymerase chain reaction. The expression of these microRNA was also analyzed in other myeloproliferative disorders. RESULTS: We observed down-regulation of let-7a and up-regulation of miR-182 in polycythemia vera granulocytes, up-regulation of miR-143, miR-145 and miR-223 in polycythemia vera mononuclear cells, up-regulation of miR-26b in polycythemia vera platelets, and down-regulation of miR-30b, miR-30c and miR-150 in polycythemia vera reticulocytes. JAK2 V617F frequency was positively correlated with miR-143 expression and inversely correlated with let-7a, miR-30c, miR-342 and miR-150. Transcript level of predicted target genes was determined, and overexpression of IRAK2 was detected in all granulocytes from patients with myeloproliferative disorders and in polycythemia vera reticulocytes. Abnormally high HMGA2 microRNA was found in myelofibrosis granulocytes. CONCLUSIONS: Our study demonstrates that peripheral blood cells from patients with polycythemia vera have microRNA signatures distinct from those of controls. Our findings of aberrant microRNA expression underline the complexity of the molecular basis of polycythemia vera.
536    __
$c Grant Number: 1P01CA108671-01A2 (United States NCI NIH HHS)
536    __
$c Grant Number: R01HL50077-11 (United States NHLBI NIH HHS)
590    __
$a bohemika - dle Pubmed
650    02
$a buněčná diferenciace $7 D002454
650    02
$a buněčný rodokmen $7 D019070
650    12
$a stanovení celkové genové exprese $7 D020869
650    12
$a regulace genové exprese $7 D005786
650    02
$a granulocyty $x cytologie $7 D006098
650    02
$a hematopoéza $7 D006410
650    02
$a lidé $7 D006801
650    02
$a Janus kinasa 2 $x genetika $7 D053614
650    02
$a leukocyty mononukleární $x cytologie $7 D007963
650    02
$a mikro RNA $x metabolismus $7 D035683
650    12
$a mikro RNA $7 D035683
650    12
$a mutace $7 D009154
650    02
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
650    12
$a polycythaemia vera $x genetika $x metabolismus $7 D011087
650    02
$a primární myelofibróza $x metabolismus $7 D055728
650    02
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dostálová, Michaela $7 xx0164071 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Prchal, Josef T. $7 xx0148595 $u University of Utah, School of Medicine, Hematology Division, Salt Lake City, Utah 84132, USA; Department of Pathophysiology, 1st School of Medicine, Charles University, Prague, Czech Republic
773    0_
$t Haematologica $g Roč. 93, č. 7 (2008), s. 1009-1016 $p Haematologica $x 0390-6078 $w MED00001963
773    0_
$p Haematologica $g 93(7):1009-16, 2008 Jul
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140714145229 $b ABA008
991    __
$a 20190104130156 $b ABA008
999    __
$a ok $b bmc $g 1032734 $s 864037
BAS    __
$a 3
BMC    __
$a 2008 $b 93 $c 7 $d 1009-1016 $i 0390-6078 $m Haematologica $x MED00001963 $n Haematologica
GRA    __
$a NR9236 $p MZ0
LZP    __
$a 2014-07/gvbo

Najít záznam

Citační ukazatele

Možnosti archivace